We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein-Coding Genetic Variant Related to Crohn's Disease

By Labmedica staff writers
Posted on 21 May 2008
A protein-coding genetic variation was identified that provides evidence for an abnormal immune response to bacteria in the digestive tract that may lead to the intestinal inflammation characteristic of Crohn's disease.

A team of scientists tested DNA samples from patients with Crohn's disease, comparing them with normal DNA samples. More...
The investigators conducted a genome-wide association scan of approximately 20,000 ‘coding' genetic variants that are thought to produce functional changes at the protein level. A novel genetic variant in a gene was identified and verified that had not been previously associated with Crohn's disease. The protein-coding genetic variation identified provides evidence that an abnormal immune response to bacteria in the digestive tract may lead to the intestinal inflammation characteristic of Crohn's disease.

The University Hospital of the Christian-Albrechts University (Kiel, Germany), together with Applied Biosystems (Foster City, CA, USA), developed the methods that led to the identification of the novel genetic variant. The collaboration led to the discovery of another piece of the genetic puzzle that may predispose humans to Crohn's disease, demonstrating a discovery pipeline that can be applied to other common disorders. Applied Biosystems single nucleotide polymorphisms (SNPs) genotyping system and other Applied Biosystems technologies including the AB 3730 genetic analyzer and TaqMan SNP genotyping assays were used for the study.

The editors of Bio-IT [Information Technology] World honored Applied Biosystems and Christian-Albrechts University with a Bio-IT World 2008 Best Practices Award for Basic Research R&D.

Bio-IT World's Best Practices Award program, which was established in 2003, recognizes teams for their novel and innovative use of technology to improve the efficiency and economics of R&D, drug discovery, clinical research, and trials. The award program is meant to bring broader awareness to the life science field's most innovative best practices and encourage the sharing of information among the scientific community.

The results of this collaboration were published in the February 2007 issue of the journal Nature Genetics. In addition, Bio-IT World plans to publish more information about this study.


Related Links:
Christian-Albrechts University
Applied Biosystems

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.